Skip to main content

Advertisement

SpringerLink
Log in

Sentinel node biopsy and selective lymph node clearance—impact on regional control and survival in breast cancer and melanoma

  • Editorial
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Morton DL, Wen D-R, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392–9.

    CAS  PubMed  Google Scholar 

  2. Nieweg OE, Jansen L, Valdés Olmos RA, Rutgers EJ, Peterse JL, Hoefnagel CA, et al. Lymphatic mapping and sentinel lymph node biopsy in breast cancer. Eur J Nucl Med 1999;26(Suppl):S11–6.

    Article  CAS  PubMed  Google Scholar 

  3. Nieweg OE. Commentary. Omitting axillary lymph node dissection in sentinel node-negative breast cancer patients appears safe. J Surg Oncol 2004; 88:7–8.

    Article  Google Scholar 

  4. Haid A, Konstantiniuk P, Köberle-Wührer R, Gebhard B, Schrenk P, Pöstelberger S, et al. Rezidive und Morbidität nach Sentinel-Lymphknotenbiopsie. Senologie 2004 Basel, Gemeinsame Jahrestagung der Österreichischen und der Schweizerischen Gesellschaft für Senologie, 20–21. 2004. Abstract

  5. Naik AM, Fey J, Gemignani M, Heerdt A, Montgomery L, Petrek J, et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4,008 procedures. Ann Surg 2004;240:462–8.

    PubMed  Google Scholar 

  6. Fredriksson I, Liljegren G, Arnesson LG, Emdin SO, Palm-Sjovall M, Fornander T, et al. Consequences of axillary recurrence after conservative breast surgery. Br J Surg 2002;89:902–8.

    Article  CAS  PubMed  Google Scholar 

  7. Recht A, Pierce SM, Abner A, Vicini F, Osteen RT, Love SM, et al. Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 1991;9:988–96.

    CAS  PubMed  Google Scholar 

  8. Nieweg OE, Tanis PJ, De Vries JDH, Kroon BBR. Sensitivity of sentinel node biopsy in melanoma. J Surg Oncol 2001;78:223–4.

    Article  CAS  PubMed  Google Scholar 

  9. Nieweg OE, Tanis PJ, Rutgers EJT. Summary of the second international sentinel node conference. Eur J Nucl Med 2001;28:646–9.

    Article  CAS  PubMed  Google Scholar 

  10. Tsao H, Atkins MB, Sober AJ. Management of cutaneous melanoma. N Engl J Med 2004;351:998–1012.

    Article  CAS  PubMed  Google Scholar 

  11. Statius Muller MG, van Leeuwen PA, de Lange-De Klerk ES, van Diest PJ, Pijpers R, Ferwerda CC, et al. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with stage I or II cutaneous melanoma. Cancer 2001;91:2401–8.

    Article  CAS  PubMed  Google Scholar 

  12. Estourgie SH, Nieweg OE, Valdés Olmos RA, Hoefnagel CA, Kroon BBR. Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years. Ann Surg Oncol 2003;10:681–8.

    Article  PubMed  Google Scholar 

  13. Clary BM, Brady MS, Lewis JJ, Coit DG. Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence. Ann Surg 2001;233:250–8.

    Article  CAS  PubMed  Google Scholar 

  14. Harlow SP, Krag DN, Ashikaga T, Weaver DL, Meijer SJ, Loggie BW, et al. Gamma probe guided biopsy of the sentinel node in malignant melanoma: a multicentre study. Melanoma Res 2001;11:45–55.

    Article  CAS  PubMed  Google Scholar 

  15. Cascinelli N, Belli F, Santinami M, Fait V, Testori A, Ruka W, et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO melanoma program experience. Ann Surg Oncol 2000;7:469–74.

    Article  CAS  PubMed  Google Scholar 

  16. Gershenwald JE, Thompson W, Mansfield PF, Lee JE, Colome MI, Tseng CH, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999;17:976–83.

    CAS  PubMed  Google Scholar 

  17. Morton DL, Hoon DS, Cochran AJ, Turner RR, Essner R, Takeuchi H, et al. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg 2003;238:538–49.

    PubMed  Google Scholar 

  18. Kretschmer L, Hilgers R, Mohrle M, Balda BR, Breuninger H, Konz B, et al. Patients with lymphatic metastasis of cutaneous malignant melanoma benefit from sentinel lymphonodectomy and early excision of their nodal disease. Eur J Cancer 2004;40:212–8.

    Article  CAS  PubMed  Google Scholar 

  19. Vuylsteke RJ, van Leeuwen PA, Muller MG, Gietema HA, Kragt DR, Meijer S. Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: long-term follow-up results. J Clin Oncol 2003;21:1057–65.

    Article  CAS  PubMed  Google Scholar 

  20. Estourgie SH, Nieweg OE, Kroon BB. High incidence of in-transit metastases after sentinel node biopsy in patients with melanoma. Br J Surg 2004;91:1370–1.

    Article  CAS  PubMed  Google Scholar 

  21. Thomas JM, Clark MA. Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma. Eur J Surg Oncol 2004;30:686–91.

    Article  CAS  PubMed  Google Scholar 

  22. Thomas JM. Melanoma: questions for the future. Eur J Surg Oncol 1996;22:130–3.

    Article  CAS  PubMed  Google Scholar 

  23. Nieweg OE, Kapteijn BAE, Thompson JF, Kroon BBR. Lymphatic mapping and selective lymphadenectomy for melanoma: not yet standard therapy. Eur J Surg Oncol 1997;23:397–8.

    Article  CAS  PubMed  Google Scholar 

  24. Morton DL. Sentinel lymphadenectomy for patients with clinical stage I melanoma. J Surg Oncol 1997;66:267–9.

    Article  CAS  PubMed  Google Scholar 

  25. Morton DL, Chan AD. Current status of intraoperative lymphatic mapping and sentinel lymphadenectomy for melanoma: is it standard of care? J Am Coll Surg 1999;189:214–23.

    Article  CAS  PubMed  Google Scholar 

  26. Estourgie SH, Nieweg OE, Kroon BB. The sentinel node procedure in patients with melanoma. Eur J Surg Oncol 2004;30:713–4.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands

    Omgo E. Nieweg & Maartje C. van Rijk

  2. Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands

    Renato A. Valdés Olmos & Cornelis A. Hoefnagel

Authors
  1. Omgo E. Nieweg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maartje C. van Rijk
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Renato A. Valdés Olmos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cornelis A. Hoefnagel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Omgo E. Nieweg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nieweg, O.E., van Rijk, M.C., Valdés Olmos, R.A. et al. Sentinel node biopsy and selective lymph node clearance—impact on regional control and survival in breast cancer and melanoma. Eur J Nucl Med Mol Imaging 32, 631–634 (2005). https://doi.org/10.1007/s00259-005-1801-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-005-1801-4

Search

Navigation